These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15759169)

  • 1. Re-scaling social preference data: implications for modelling.
    Cleemput I; Kind P; Kesteloot K
    Eur J Health Econ; 2004 Dec; 5(4):290-8. PubMed ID: 15759169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of health states with rank-based nonmetric multidimensional scaling.
    Krabbe PF; Salomon JA; Murray CJ
    Med Decis Making; 2007; 27(4):395-405. PubMed ID: 17761959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.
    Johnson JA; Ohinmaa A; Murti B; Sintonen H; Coons SJ
    Med Decis Making; 2000; 20(3):281-9. PubMed ID: 10929850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling a preference-based index for EQ-5D using a non-parametric Bayesian method.
    Kharroubi SA; Daher CA
    Qual Life Res; 2018 Nov; 27(11):2841-2850. PubMed ID: 30008157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuation of EuroQOL (EQ-5D) health states in an adult US sample.
    Johnson JA; Coons SJ; Ergo A; Szava-Kovats G
    Pharmacoeconomics; 1998 Apr; 13(4):421-33. PubMed ID: 10178666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With Dementia.
    Webb EJD; Meads D; Al-Janabi H; Kind P; Torelli F; Horton M; Oyebode J; Wright P
    Value Health; 2020 Aug; 23(8):1079-1086. PubMed ID: 32828221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using EQ-5D Data to Measure Hospital Performance: Are General Population Values Distorting Patients' Choices?
    Gutacker N; Patton T; Shah K; Parkin D
    Med Decis Making; 2020 May; 40(4):511-521. PubMed ID: 32486958
    [No Abstract]   [Full Text] [Related]  

  • 16. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D.
    Ratcliffe J; Flynn T; Terlich F; Stevens K; Brazier J; Sawyer M
    Pharmacoeconomics; 2012 Aug; 30(8):713-27. PubMed ID: 22788261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions.
    McPherson K; Myers J; Taylor WJ; McNaughton HK; Weatherall M
    Med Care; 2004 Nov; 42(11):1143-51. PubMed ID: 15586842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state valuations from the general public using the visual analogue scale.
    Gudex C; Dolan P; Kind P; Williams A
    Qual Life Res; 1996 Dec; 5(6):521-31. PubMed ID: 8993098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thurstone scaling revealed systematic health-state valuation differences between patients with dementia and proxies.
    Arons AM; Krabbe PF; Schölzel-Dorenbos CJ; van der Wilt GJ; Olde Rikkert MG
    J Clin Epidemiol; 2012 Aug; 65(8):897-905. PubMed ID: 22652351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.